Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
EV/Core EBITDA

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 12.236.325.185.352.57

What is the latest EV/Core EBITDA ratio of MARKSANS PHARMA ?

The latest EV/Core EBITDA ratio of MARKSANS PHARMA is 12.23 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202412.23
Mar20236.32
Mar20225.18
Mar20215.35
Mar20202.57

How is EV/Core EBITDA of MARKSANS PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 12.23
93.51
Mar2023 6.32
22.01
Mar2022 5.18
-3.18
Mar2021 5.35
108.17
Mar2020 2.57 -

Other Financial Ratios of MARKSANS PHARMA


Compare EV/Core EBITDA ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,761.4 Cr -2.7% -1.7% 97.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,920.0 Cr -0.1% 1.7% 45.7% Stock Analytics
DIVIS LABORATORIES ₹155,160.0 Cr -0.1% -2.2% 56.9% Stock Analytics
CIPLA ₹118,917.0 Cr 1.7% 0.5% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹112,017.0 Cr 5.7% 12.4% 18.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,997.1 Cr -1.4% 3.1% 44.8% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2.7%

-1.7%

97.1%

SENSEX

-5%

0.6%

9.2%


You may also like the below Video Courses